These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

33 related articles for article (PubMed ID: 16241965)

  • 1. On the dosing of lepirudin.
    Alberio L; Lämmle B
    Br J Clin Pharmacol; 2011 Oct; 72(4):717. PubMed ID: 21812803
    [No Abstract]   [Full Text] [Related]  

  • 2. Direct thrombin inhibitors: pharmacology and application in intensive care medicine.
    Schaden E; Kozek-Langenecker SA
    Intensive Care Med; 2010 Jul; 36(7):1127-37. PubMed ID: 20425104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombosis during lepirudin therapy: a case report.
    Wallet F; Bayle F; Leray V; Richard JC; Bourdin G; Guérin C
    Intensive Care Med; 2009 May; 35(5):959-60. PubMed ID: 19034422
    [No Abstract]   [Full Text] [Related]  

  • 4. Heparin-dependent platelet factor 4 antibodies and the impact of renal function on clinical outcomes: a retrospective study in hospitalized patients.
    Perry SL; Whitlatch NL; Ortel TL
    J Thromb Thrombolysis; 2009 Aug; 28(2):146-50. PubMed ID: 18839279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dosage of lepirudin in renal failure.
    Shepherd MF
    Am J Health Syst Pharm; 2002 Jan; 59(1):77-8. PubMed ID: 11813471
    [No Abstract]   [Full Text] [Related]  

  • 6. Recommended and actual lepirudin doses in patients with renal insufficiency.
    Saxer SB; Smith BS; Gandhi PJ; Tataronis GR; Krikorian SA
    Am J Health Syst Pharm; 2003 Dec; 60(24):2588-93. PubMed ID: 14735776
    [No Abstract]   [Full Text] [Related]  

  • 7. Severe anaphylactic reaction after repeated intermittent exposure to lepirudin.
    Veach SA; Franks AM; Allan MC
    Pharmacotherapy; 2007 May; 27(5):760-5. PubMed ID: 17461712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New direct thrombin inhibitor becomes available.
    Thompson CA
    Am J Health Syst Pharm; 2010 Apr; 67(8):588. PubMed ID: 20360575
    [No Abstract]   [Full Text] [Related]  

  • 9. Lepirudin: is the approved dosing schedule too high?
    Hacquard M; de Maistre E; Lecompte T
    J Thromb Haemost; 2005 Nov; 3(11):2593-6. PubMed ID: 16241965
    [No Abstract]   [Full Text] [Related]  

  • 10. Lepirudin in the management of heparin-induced thrombocytopenia.
    Gajra A; Husain J; Smith A
    Expert Opin Drug Metab Toxicol; 2008 Aug; 4(8):1131-41. PubMed ID: 18680447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of heparin-induced thrombocytopenia in cardiovascular patients.
    Matthai WH
    Expert Opin Pharmacother; 2006 Feb; 7(3):267-76. PubMed ID: 16448321
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.